L. V. Allen, M. L. Stiles, S. J. Prince, and J. Smeeding, Stability of 14 drugs in the latex reservoir of an elastomeric infusion device, Am J Health Syst Pharm, vol.53, pp.2740-2743, 1996.

M. Arsène, P. Favetta, B. Favier, and J. Bureau, Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions, J Clin Pharm Ther, vol.27, pp.205-209, 2002.

P. P. Belliveau, C. H. Nightingale, and R. Quintiliani, Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9 % sodium chloride injection, Am J Hosp Pharm, vol.51, pp.901-904, 1994.

K. Berthoin, L. Duff, C. S. Marchand-brynaert, J. Carryn, S. Tulkens et al., Stability of meropenem and doripenem solutions for administration by continuous infusion, J Antimicrob Chemother, vol.65, pp.1073-1075, 2010.

F. P. Bigley, R. J. Forsyth, and M. W. Henley, Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions, Am J Hosp Pharm, vol.43, pp.2803-2809, 1986.

P. Chennell, L. Delaborde, M. Wasiak, M. Jouannet, E. Feschet-chassot et al., Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions, Eur J Pharm Sci, vol.100, pp.230-237, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01649316

J. Cotrina-luque, M. V. Gil-navarro, H. Acosta-garcía, E. R. Alfaro-lara, R. Luque-márquez et al., Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa, Int J Clin Pharm, vol.38, pp.70-79, 2016.

C. Curti, E. Lamy, N. Primas, C. Fersing, C. Jean et al., Stability studies of five anti-infectious eye drops under exhaustive storage conditions, Pharmazie, vol.72, pp.741-746, 2017.

R. F. Donnelly, Stability of aseptically prepared tazocin solutions in polyvinyl chloride bags, Can J Hosp Pharm, vol.62, pp.226-231, 2009.

, ICH Topic Q3C. Impurities: guideline for residual solvent, European Medicines Agency, 2010.

C. Ezquer-garin, R. Ferriols-lisart, A. , and M. , Stability of tacrolimus ophthalmic solution, Am J Health Syst Pharm, vol.74, pp.1002-1006, 2017.

P. Favetta, C. Allombert, C. Breysse, C. Dufresne, J. Guitton et al., Fortum stability in different disposable infusion devices by pyridine assay, J Pharm Biomed Anal, vol.27, pp.873-879, 2002.

M. Friciu, V. G. Roullin, and G. Leclair, Stability of gabapentin in extemporaneously compounded oral suspensions, PlosONE, vol.12, p.175208, 2017.

V. D. Gupta, J. Maswoswe, and R. E. Bailey, Stability of cefepime hydrochloride dextrose in 5 % dextrose injection and 0.9 % sodium chloride injection, Int J Pharm Compd, vol.1, pp.435-436, 1997.

V. D. Gupta and J. Ling, Stability of cefepime hydrochloride after reconstitution in 0.9 % sodium chloride injection and storage in polypropylene syringes for pediatric use, Int J Pharm Compound, vol.5, pp.151-152, 2001.

, Krämer I (1997) Stability of meropenem in elastomeric portable infusion devices, Eur Hosp Pharm, vol.3, pp.168-171

Y. R. Lee, P. D. Miller, S. K. Alzghari, D. D. Blanco, J. D. Hager et al., Continuous infusion versus intermittent bolus of beta-lactams in critically ill patients with respiratory infections: a systematic review and meta-analysis, Eur J Drug Metab Pharmacokinet, vol.43, pp.155-170, 2018.

T. P. Lodise, B. Lomaestro, and G. L. Drusano, Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy, Clin Infect Dis, vol.44, pp.357-363, 2007.

D. A. Marble, J. A. Bosso, and R. J. Townsend, Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions, Am J Hosp Pharm, vol.43, pp.1732-1736, 1986.

Y. S. Moon, K. C. Chung, A. Chin, and M. A. Gill, Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags, Am J Health Syst Pharm, vol.52, pp.999-1001, 1995.

B. Moriyama, S. A. Henning, R. Childs, S. M. Holland, V. L. Anderson et al., High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients, Ann Pharmacother, vol.44, pp.929-935, 2010.

P. R. Patel and S. E. Cook, Stability of meropenem in intravenous solutions, Am J Health-Syst Pharm, vol.54, pp.412-421, 1997.

M. C. Quinton, S. Bodeau, L. Kontar, Y. Zerbib, J. Maizel et al., Neurotoxic concentration of piperacillin during continuous infusion in critically ill Patients, Antimicrob Agents Chemother, vol.61, p.654, 2017.

J. A. Roberts, M. H. Abdul-aziz, J. S. Davis, J. M. Dulhunty, M. O. Cotta et al., Continuous versus intermittent ?-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials, Am J Respir Crit Care Med, vol.194, pp.681-691, 2016.

T. L. Stendal, W. Klem, H. H. Tonnesen, and I. Kjonniksen, Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device, Am J Health Syst Pharm, vol.55, pp.683-685, 1998.

J. T. Stewart, F. C. Maddox, and F. W. Warren, Stability of cefepime hydrochloride in polypropylene syringes, Am J Health Syst Pharm, vol.56, p.1134, 1999.

C. Tomasello, A. Leggieri, R. Cavalli, D. Perri, G. et al., In vitro stability evaluation of different pharmaceutical products containing meropenem, Hosp Pharm, vol.50, pp.296-303, 2015.

L. A. Trissel and Q. A. Xu, Stability of cefepime hydrochloride in AutoDose infusion system bags, Ann Pharmacother, vol.37, pp.804-807, 2003.

U. S. Pharmacopeia, United States Pharmacopeia: USP 23-NF18. United States Pharmacopeia, 1995.

K. Z. Vardakas, G. L. Voulgaris, A. Maliaros, G. Samonis, and M. E. Falagas, Prolonged versus short-term intravenous infusion of antipseudomonal ?-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials, Lancet Infect Dis, vol.18, pp.108-120, 2018.